Colm Burke

687. Deputy Colm Burke asked the Minister for Children, Disability and Equality to confirm whether the establishment of a specific scheme to replace the mobility allowance and motorised transport schemes (discontinued in 2013) is included within the plan of action for transport, as per the national disability strategy; and, if so, to provide a timeline for same. [53441/26]

717. Deputy Colm Burke asked the Minister for Health if her Department and the HSE have agreed to put in place a tendering process for teledermatology; the date when tenders were invited; and if she will make a statement on the matter. [52760/26]

718. Deputy Colm Burke asked the Minister for Health if her Department and the HSE have agreed on the standards and governance structures which will be put in place in respect of teledermatology to ensure that the State receives good quality outcomes when the system is in place; and if she will make a statement on the matter. [52761/26]

750. Deputy Colm Burke asked the Minister for Health her views on extending publicly funded access to continuous glucose monitoring to all women with type 2 diabetes during pregnancy; and if she will make a statement on the matter. [52893/26]

751. Deputy Colm Burke asked the Minister for Health the number of people with a clinical diagnosis of type 1 diabetes who are currently ineligible for publicly funded continuous glucose monitoring access; and if she will make a statement on the matter. [52894/26]

752. Deputy Colm Burke asked the Minister for Health if she will consider widening access to continuous glucose monitoring (CGM) for women with type 2 diabetes during pregnancy (details supplied); and if she will make a statement on the matter. [52895/26]

753. Deputy Colm Burke asked the Minister for Health if the ongoing review of the preferred continuous glucose monitoring (CGM) sensors evaluation will encompass a consideration of ensuring that all patients with type one diabetes have access to CGM; and if she will make a statement on the matter. [52898/26]

754. Deputy Colm Burke asked the Minister for Health whether the ongoing review of the preferred continuous glucose monitoring (CGM) sensors evaluation will lead to a HTA of CGM sensors for patients with type 2 diabetes; and if she will make a statement on the matter. [52899/26]

11. Deputy Colm Burke asked the Minister for Agriculture, Food and the Marine the additional measures he is considering to support farm incomes in light of rising input costs and challenges facing the agricultural sector; and if he will make a statement on the matter. [52226/26]

14. Deputy Colm Burke asked the Minister for Agriculture, Food and the Marine the further steps he and his Department are taking to encourage more young people to enter farming and to support family farm succession; and if he will make a statement on the matter. [52227/26]

64. Deputy Colm Burke asked the Tánaiste and Minister for Finance the number of meetings of the Working Party on Tax Questions, including meetings dealing with indirect taxation, that are scheduled or expected to take place during the Irish Presidency of the Council of the European Union; whether the revision of the Tobacco Taxation Directive is expected to feature on the agenda of any such meeting; and if he will make a statement on the matter. [52118/26]

65. Deputy Colm Burke asked the Tánaiste and Minister for Finance whether Ireland intends to table or support a Presidency compromise text on the revision of the Tobacco Taxation Directive during its Presidency of the Council of the European Union; whether he expects the file to be brought to ECOFIN for political agreement before the end of the Irish Presidency; and if he will make a statement on the matter. [52119/26]

66. Deputy Colm Burke asked the Tánaiste and Minister for Finance whether, in seeking agreement on the Tobacco Taxation Directive, Ireland will support the inclusion of novel nicotine products, including e-cigarettes, heated tobacco products and nicotine pouches, within the EU excise framework; whether Ireland supports minimum excise rates that reflect public-health objectives as well as internal-market considerations; and if he will make a statement on the matter. [52120/26]

134. Deputy Colm Burke asked the Minister for Social Protection to provide an estimate of the accumulated total in cuts in spending on the dental treatment service scheme since 2010 as compared with the baseline annual total spent in 2009; and if he will make a statement on the matter. [52253/26]

135. Deputy Colm Burke asked the Minister for Social Protection to provide an estimate on the amount that would have been spent on the dental treatment service scheme in 2025 if spending had been maintained at 2009 levels with CPI applied in the intervening period and taking into account the current numbers of citizens eligible to receive PRSI benefit; and if he will make a statement on the matter. [52254/26]

163. Deputy Colm Burke asked the Minister for Justice, Home Affairs and Migration if consideration will be given to expediting an IRP application for a person (details supplied) due to technical issues experienced by the family during the application leading to an error, refusal and reapplication; and if he will make a statement on the matter. [52236/26]

223. Deputy Colm Burke asked the Minister for Health the steps being taken to procure additional ophthalmology service provision to address the needs of the more than 58,000 patients currently on waiting lists for ophthalmology care nationwide; when the next National Treatment Purchase Fund Framework for waiting list activity is expected to be published; when procurement under that framework is expected to commence; and if she will make a statement on the matter. [52065/26]

229. Deputy Colm Burke asked the Minister for Health whether the conference being organised by her Department on 16 and 17 November 2026, entitled "Maximising EU Potential through Health - Securing Our Future Through Prevention, Innovation and Equity", will include any dedicated session, panel, speaker contribution or outcome document addressing tobacco control, novel nicotine products, youth vaping, or preparations for a revised Tobacco Products Directive; and if she will make a statement on the matter. [52111/26]

230. Deputy Colm Burke asked the Minister for Health whether, during Ireland's Presidency of the Council of the European Union, if she intends to seek a dedicated discussion at EPSCO Health Council, including under Any Other Business if necessary, on the need to expedite the revision of the Tobacco Products Directive and Tobacco Advertising Directive; whether she has raised or intends to raise this matter directly with the European Commissioner for Health; and if she will make a statement on the matter. [52112/26]

231. Deputy Colm Burke asked the Minister for Health the plans to work with the Member States that joined Ireland in the March 2025 letter to the European Commission calling for urgent progress on EU tobacco-control legislation, including Belgium, Estonia, Finland, France, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Slovenia and Spain, with a view to securing renewed Council-level momentum during the Irish Presidency; whether any such contacts have taken place; and if she will make a statement on the matter. [52113/26]

232. Deputy Colm Burke asked the Minister for Health the number of meetings of the Working Party on Public Health that are scheduled or expected to take place during the Irish Presidency of the Council of the European Union; whether tobacco control, novel nicotine products, youth vaping, or the revision of the Tobacco Products Directive are expected to feature on the agenda of any such meeting; and whether Ireland intends to table any Presidency paper, discussion note or draft Council conclusions on these issues. [52114/26]

233. Deputy Colm Burke asked the Minister for Health whether tobacco control, novel nicotine products, youth vaping, or preparation for a revised Tobacco Products Directive will feature in the conference being organised in Dublin from 15 to 18 September 2026, entitled "2026 Annual Conference of the European Society for Prevention Research on Innovation in Prevention to Support Health Equity"; whether her Department is involved in shaping the agenda or outcomes of that conference; and if she will make a statement on the matter. [52115/26]

234. Deputy Colm Burke asked the Minister for Health whether she plans to facilitate exchanges between the European Commission, Council officials, Member State health attachés and public-health stakeholders, including through workshops, technical meetings or Presidency events, to support a comprehensive and expedited revision of the Tobacco Products Directive and Tobacco Advertising Directive; and if she will make a statement on the matter. [52116/26]

235. Deputy Colm Burke asked the Minister for Health whether Ireland intends to seek council conclusions, a Presidency statement, or another formal Presidency output during its EU Council Presidency calling for stronger EU action on tobacco control, including action on novel nicotine products, youth vaping, cross-border marketing, flavours, packaging and online sales; and if she will make a statement on the matter. [52117/26]

250. Deputy Colm Burke asked the Minister for Health her views on the fact that while the number of NHDs has risen by 52% between 2012 and 2021, the number of hospital consultants has risen by 44% over the past decade, while the number of nurses and midwives has risen by 36% and the number of administrators and managers has risen by 50%, the number of dentists employed by the HSE has in fact fallen by 30% between 2009 and 2024; and if she will make a statement on the matter. [52250/26]